VivoSeq
Other

Executive Function

16

Pipeline Programs

4

Active Trials

11

Companies Involved

Executive Function is an emerging landscape with 16 programs across 11 companies. The most active players are Pascoe Pharmazeutische Praeparate GmbH, Takeda, Promius Pharma, LLC. 10 therapies are approved with 1 more in late-stage development.

Pipeline Metrics

Competitive Density

44/100

Pipeline Velocity

11/100

Mech. Concentration

22/100

Completion Rate

92/100

Attrition Rate

5/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

19

clinical trials

Completed11 · 58%
Unknown status3 · 16%
Recruiting2 · 11%
Withdrawn1 · 5%
Active, not recruiting1 · 5%
Not yet recruiting1 · 5%

Trial Activity

19 trials

IMProving Executive Function Study
Completed·UUniversity of Pennsylvania·Phase 4·NCT03187353·69 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)